Literature DB >> 27449217

Patient and Physician Factors Associated with Undisclosed Prostate Cancer Screening in a Sample of Predominantly Immigrant Black Men.

Stephen J Lepore1, Rasmi G Nair2, Stacy N Davis3, Randi L Wolf4, Charles E Basch4, Nigel Thomas5, Celia Shmukler5, Ralph Ullman5.   

Abstract

Medical guidelines do not recommend prostate cancer screening, particularly without informed and shared decision making. This study investigates undisclosed opportunistic screening using prostate specific antigen (PSA) testing in black immigrant and African American men. Participants (N = 142) were insured urban men, 45- to 70-years old. Patients' reports of testing were compared with medical claims to assess undisclosed PSA testing. Most (94.4 %) men preferred to share in screening decisions, but few (46.5 %) were aware PSA testing was performed. Four factors predicted being unaware of testing: low formal education, low knowledge about prostate cancer, no intention to screen, and no physician recommendation (all p's < .05). Undisclosed PSA testing was common. Both patient and provider factors increased risk of being uninformed about prostate cancer screening. Interventions combining patient education and physician engagement in shared decision making may better align practice with current prostate cancer screening guidelines.

Entities:  

Keywords:  Informed decision making; Minority health; Patient preferences; Prostate cancer screening; Shared decision making

Mesh:

Substances:

Year:  2017        PMID: 27449217      PMCID: PMC5407941          DOI: 10.1007/s10903-016-0468-1

Source DB:  PubMed          Journal:  J Immigr Minor Health        ISSN: 1557-1912


  45 in total

Review 1.  Screening for prostate cancer. American College of Physicians.

Authors: 
Journal:  Ann Intern Med       Date:  1997-03-15       Impact factor: 25.391

2.  Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA).

Authors: 
Journal:  Oncology (Williston Park)       Date:  2000-02       Impact factor: 2.990

3.  Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?

Authors:  K J O'Dell; R J Volk; A R Cass; S J Spann
Journal:  J Fam Pract       Date:  1999-09       Impact factor: 0.493

4.  American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection.

Authors:  R A Smith; A C von Eschenbach; R Wender; B Levin; T Byers; D Rothenberger; D Brooks; W Creasman; C Cohen; C Runowicz; D Saslow; V Cokkinides; H Eyre
Journal:  CA Cancer J Clin       Date:  2001 Jan-Feb       Impact factor: 508.702

5.  Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial.

Authors:  Rebecka Arnsrud Godtman; Erik Holmberg; Hans Lilja; Johan Stranne; Jonas Hugosson
Journal:  Eur Urol       Date:  2014-12-31       Impact factor: 20.096

6.  Fostering informed decisions: a randomized controlled trial assessing the impact of a decision aid among men registered to undergo mass screening for prostate cancer.

Authors:  Randi M Williams; Kimberly M Davis; George Luta; Sara N Edmond; Caroline S Dorfman; Marc D Schwartz; John Lynch; Chiledum Ahaghotu; Kathryn L Taylor
Journal:  Patient Educ Couns       Date:  2013-01-26

7.  Shared decision making: Concepts, evidence, and practice.

Authors:  A M Stiggelbout; A H Pieterse; J C J M De Haes
Journal:  Patient Educ Couns       Date:  2015-07-15

8.  Patterns in prostate-specific antigen test use and digital rectal examinations in the Behavioral Risk Factor Surveillance System, 2002-2006.

Authors:  Louie E Ross; Yhenneko J Taylor; Lisa C Richardson; Daniel L Howard
Journal:  J Natl Med Assoc       Date:  2009-04       Impact factor: 1.798

9.  Relationship Between Clerical Burden and Characteristics of the Electronic Environment With Physician Burnout and Professional Satisfaction.

Authors:  Tait D Shanafelt; Lotte N Dyrbye; Christine Sinsky; Omar Hasan; Daniel Satele; Jeff Sloan; Colin P West
Journal:  Mayo Clin Proc       Date:  2016-06-27       Impact factor: 7.616

10.  Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study.

Authors:  Carmen E Guerra; Samantha E Jacobs; John H Holmes; Judy A Shea
Journal:  J Gen Intern Med       Date:  2007-07       Impact factor: 5.128

View more
  3 in total

1.  Associations of Prostate-Specific Antigen (PSA) Testing in the US Population: Results from a National Cross-Sectional Survey.

Authors:  Jarrett A Johnson; Richard P Moser; Gary L Ellison; Damali N Martin
Journal:  J Community Health       Date:  2020-10-16

2.  An Exploration of Precancer and Post-Cancer Diagnosis and Health Communication Among African American Prostate Cancer Survivors and Their Families.

Authors:  Sabrina L Dickey; Caneisaya Matthews; Eugenia Millender
Journal:  Am J Mens Health       Date:  2020 May-Jun

3.  Physician engagement: a concept analysis.

Authors:  Tyrone A Perreira; Laure Perrier; Melissa Prokopy; Lina Neves-Mera; D David Persaud
Journal:  J Healthc Leadersh       Date:  2019-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.